Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05046821 · ClinicalTrials.gov registry record
Sporadic Inclusion Body Myositis Natural History Study
A clinical trial of Inclusion Body Myositis and Sporadic Inclusion Body Myositis, sponsored by University of California, Irvine.
- Active
- Registry status
- 150
- Enrollment target
- 13
- Study locations
NCT05046821: Active study of Inclusion Body Myositis and Sporadic Inclusion Body Myositis, sponsored by University of California, Irvine.
NCT05046821 is a study of Inclusion Body Myositis and Sporadic Inclusion Body Myositis that is active but no longer recruiting, run by University of California, Irvine. The registered enrollment target is 150 participants, below the 221-participant average among 10 other Inclusion Body Myositis trials with a reported enrollment target (32% lower). The trial reports 13 study locations across 12 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05046821, a study of Inclusion Body Myositis and Sporadic Inclusion Body Myositis, is active but no longer recruiting, sponsored by University of California, Irvine.
- ACTIVE NOT RECRUITING
- Registry status
- 150 participants
- Enrollment target
- 13
- Study locations
Study Summary
This is a prospective natural history study on patients with clinically defined sIBM. Participants will be assessed every 6 months over two years (five visits total). We will include 150 participants, enrolled across 13 sites, with sporadic IBM, diagnosed according to established criteria.
Primary Outcome
The IBMFRS is a 10 item questionnaire. Scores for each item range from 0 to 4. There is a total maximum score of 40 and minimum score of 0. The higher the score the better functional status of the person.
Conditions Studied
Study Locations (13)
California
- University of California, Los Angeles - Los Angeles
- University of California, Irvine - Orange
Colorado
- University of Colorado - Aurora
Florida
- University of Miami - Miami
Kansas
- Kansas University Medical Center - Fairway
Maryland
- Johns Hopkins University - Baltimore
Massachusetts
- Brigham and Women's Hospital - Boston
Missouri
- Washington University in St. Louis - St Louis
Ohio
- Ohio State University - Columbus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2021-10-11 |
| Est. Completion | 2027-03-31 |
What the registry record for NCT05046821 still lists
NCT05046821 is an observational study that tracks outcomes without assigning an intervention. The registered 150 participants enrollment target is mid-sized for trials with a published cap, below the 221-participant average among 10 other Inclusion Body Myositis trials with a reported enrollment target (32% lower).
The record links to 2 conditions, with Inclusion Body Myositis appearing as the primary indexed condition, and to 0 interventions.
NCT05046821 lists 13 locations in 12 states (California, Colorado, Florida).
Frequently Asked Questions
What is clinical trial NCT05046821 about?
NCT05046821 is a clinical study titled "Sporadic Inclusion Body Myositis Natural History Study". This is a prospective natural history study on patients with clinically defined sIBM. Participants will be assessed every 6 months over two years (five visits total). We will include 150 participants, enrolled across 13 sites, with sporadic IBM, diagnosed according to established criteria.
What is the current status of trial NCT05046821?
This trial is currently active not recruiting. The enrollment target is 150 participants. The study started on 2021-10-11. Estimated completion is 2027-03-31.
What conditions does trial NCT05046821 study?
This clinical trial studies the following conditions: Inclusion Body Myositis, Sporadic Inclusion Body Myositis.
Who is sponsoring clinical trial NCT05046821?
This trial is sponsored by University of California, Irvine, which has 368 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05046821 being conducted?
This trial has 13 study locations across California, Colorado, Florida, Kansas, Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Inclusion Body Myositis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05046821's enrollment target sits among peer trials
150 3rd of 10 higher than 8 of 10 other Inclusion Body Myositis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Inclusion Body Myositis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Effects of Whole-body Electrical Muscle Stimulation Exercise on Adults With Neuromuscular Disease
RECRUITING · NA
-
Adult and Juvenile Myositis
RECRUITING
-
MIHRA - Patient-Rooted Insights for Shaping Myositis Science (PRISMS)
RECRUITING
-
Phase III Trial of Sirolimus in IBM
ACTIVE NOT RECRUITING · Phase 3
-
Monitoring Biomarker for Detecting Change in Physical Activity and Limb Function in Inclusion Body Myositis Over Time
ACTIVE NOT RECRUITING
-
Inclusion Body Myositis Treatment With Celution Processed Adipose Derived Regenerative Cells
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00412594 · 150 participants · Phase 2
Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia
- NCT01484730 · 150 participants
A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion
- NCT01985919 · 150 participants
Protocol for Facilitating the Acquisition of Research Bone Marrow and Blood Samples
- NCT02016248 · 150 participants · NA
SBRT Boost for Unfavorable Prostate Cancer'
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI